Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

Share Price is delayed by 15 minutes
Get Live Data
4,890.00    130.00 (2.73%)
Bid:
4,894.00
Ask:
4,898.00
Spread: 4.00 (0.082%)
Market Cap: £17.82b
CCH Live PriceLast checked at - London Stock Exchange

Intraday Coca-Cola HBC Share Chart

Director/PDMR Shareholding

4 Jan 2022 09:54

RNS Number : 3425X
Coca-Cola HBC AG
04 January 2022
Β 

FOR IMMEDIATE RELEASE

04 January 2022

Β 

Coca-Cola HBC AG (the "Company")

Notification of transactions by Persons Discharging Managerial Responsibilities ("PDMRs')

The Company announces that the deferred bonus award over shares of CHF 6.70 in the Company (the "Deferred Shares") granted under the Company's Management Incentive Plan to Zoran Bogdanovic, Chief Executive Officer, relating to a performance related annual bonus for 2018 vested on 31 December 2021. Following vesting, the PDMR sold sufficient Deferred Shares to cover his tax and other liabilities and the balance of the Deferred Shares was retained.

Β PDMR

Number of shares granted under the Deferred Shares vesting

Number of shares sold to cover taxes and other liabilities

Number of shares retained

Zoran Bogdanovic, Chief Executive Officer

7,717

450

7,267

Β 

The Notification of Dealing Form can be found below.

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

a)

Β 

Name

Β 

ZORAN BOGDANOVIC

Β 

2

Β 

Reason for the notification

a)

Β 

Position/status

Β 

CHIEF EXECUTIVE OFFICER

b)

Β 

Initial notification /Amendment

Β 

INITIAL NOTIFICATION

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Β 

Name

Β 

COCA-COLA HBC AG

b)

Β 

LEI

Β 

549300EFP3TNG7JGVE49

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Β 

COCA-COLA HBC AG ORDINARY SHARES OF CHF 6.70 EACH ("SHARES")

Β 

CH0198251305

b)

Β 

Nature of the transaction

Β 

Β 

VESTING OF DEFERRED SHARES GRANTED IN MARCH 2019 UNDER THE COMPANY'S MANAGEMENT INCENTIVE PLAN

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

Price(s)

Volume(s)

25.47 GBP

7,717

d)

Β 

Aggregated information

Β 

- Aggregated volume

Β 

- Price

Β 

Β 

Price

Volume

Total

25.47 GBP

7,717

196,551.99 GBP

e)

Β 

Date of the transaction

Β 

2021-12-31

f)

Β 

Place of the transaction

Β 

XLON

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Β 

COCA-COLA HBC AG ORDINARY SHARES OF CHF 6.70 EACH ("SHARES")

Β 

CH0198251305

b)

Β 

Nature of the transaction

Β 

Β 

SALE OF SHARES TO COVER TAX AND OTHER LIABILITIES ARISING FROM VESTING OF THE DEFERRED SHARES

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

Price(s)

Volume(s)

25.47 GBP

450

d)

Β 

Aggregated information

Β 

- Aggregated volume

Β 

- Price

Β 

Β 

Price

Volume

Total

25.47 GBP

450

11,461.50 GBP

e)

Β 

Date of the transaction

Β 

2021-12-31

f)

Β 

Place of the transaction

Β 

XLON

Β 

Β 

This notification is made in accordance with the requirements of the UK Market Abuse Regulation and EU Market Abuse Regulation.

For further information, please contact:

Jan Gustavsson

General Counsel and Company Secretary

+41 (0) 41 726 01 10

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHBKQBPCBKKBDK
Date   Source Headline
20th Feb 20232:13 pmRNSDirector/PDMR Shareholding
16th Feb 202311:28 amRNSDirector/PDMR Shareholding
14th Feb 20237:00 amRNSStrong execution drives another year of growth
1st Feb 20231:50 pmRNSIssue of equity and total voting rights
18th Jan 20232:47 pmRNSDirector/PDMR Shareholding
17th Jan 20239:34 amRNSNotice of Results
5th Jan 202310:14 amRNSAthens Exchange trading date of ordinary shares
4th Jan 20233:02 pmRNSDirector/PDMR Shareholding
20th Dec 202210:16 amRNSPost 2022 AGM Shareholder Engagement
19th Dec 20223:03 pmRNSDirector/PDMR Shareholding
1st Dec 20227:44 amRNSIssue of equity and total voting rights
18th Nov 20223:13 pmRNSDirector/PDMR Shareholding
17th Nov 20228:41 amRNSDirector/PDMR Shareholding
16th Nov 20225:06 pmRNSDirector/PDMR Shareholding
14th Nov 20222:36 pmRNSDirector/PDMR Shareholding
11th Nov 20221:32 pmRNSDirector/PDMR Shareholding
11th Nov 20221:24 pmRNSDirector/PDMR Shareholding
8th Nov 20227:00 amRNSContinued positive momentum
1st Nov 20222:50 pmRNSBlock listing Interim Review
18th Oct 20223:05 pmRNSDirector/PDMR Shareholding
13th Oct 202210:40 amRNSNotice of Results
3rd Oct 202210:03 amRNSIssue of equity and total voting rights
28th Sep 20221:28 pmRNSDirector/PDMR Shareholding
21st Sep 20225:07 pmRNSIssue of Debt
20th Sep 202211:51 amRNSDirector/PDMR Shareholding
16th Sep 202212:32 pmRNS2022 Performance Share Plan Awards
15th Sep 20225:21 pmRNSIssue of Debt
15th Sep 20222:44 pmRNSHolding(s) in Company
15th Sep 20228:49 amRNSIssue of Debt
13th Sep 202212:38 pmRNSDirector/PDMR Shareholding
7th Sep 202212:05 pmRNSHolding(s) in Company
6th Sep 20222:03 pmRNSPublication of a Prospectus
30th Aug 20229:14 amRNSHolding(s) in Company
25th Aug 20229:01 amRNSHolding(s) in Company
23rd Aug 20221:45 pmRNSHolding(s) in Company
23rd Aug 202211:06 amRNSHolding(s) in Company
18th Aug 20223:43 pmRNSHolding(s) in Company
18th Aug 202212:05 pmRNSHolding(s) in Company
18th Aug 202211:24 amRNSDirector/PDMR Shareholding
11th Aug 202212:40 pmRNSHolding(s) in Company
11th Aug 20227:00 amRNSStrong volumes, revenue, EBIT; investing in growth
9th Aug 20221:45 pmRNSDirector/PDMR Shareholding
9th Aug 20227:00 amRNSCCH agrees to acquire Three Cents
19th Jul 202212:53 pmRNSDirector/PDMR Shareholding
19th Jul 202210:48 amRNSNotice of Results
22nd Jun 202210:45 amRNSHolding(s) in Company
21st Jun 20224:28 pmRNSResult of AGM
20th Jun 20222:38 pmRNSDirector/PDMR Shareholding
8th Jun 20221:02 pmRNSAthens Exchange trading date of ordinary shares
6th Jun 20229:32 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.